The potential role of HCV core antigen testing in diagnosing HCV infection

Antiviral Therapy

Volumn 17, Issue 7 PARTB, 2012, Pages 1431-1435

  Dawson, GeorgeJ ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS C ANTIGEN; HEPATITIS C CORE ANTIGEN; UNCLASSIFIED DRUG; VIRUS RNA;

ANTIGEN DETECTION; BLOOD ANALYSIS; DIAGNOSTIC TEST; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS CORE ANTIGEN TEST; HUMAN; INFECTION RISK; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SEROCONVERSION;

BLOOD BANKS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; VIRAL CORE PROTEINS;

EID: 84872000411     PISSN: 13596535     EISSN: 20402058     Source Type: Journal    
DOI: 10.3851/IMP2463     Document Type: Review

References (20)

1. Takahashi K, Okamoto H, Kishimoto S, et al. Demonstration of a hepatitis C virus-specific antigen predicted from the putative core gene in the circulation of infected hosts. J Gen Virol 1992; 73:667-672.
2. Tanaka T, Lau JYH, Mizokami M, et al. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia. J Hepatol 1995; 23:742-745. (Pubitemid 26013285)
3. Morota K, Fujinami R, Kinukawa H, et al. A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C core antigen. J Virol Methods 2009; 157:8-14.
4. Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 2005; 436:946-952. (Pubitemid 41191670)
5. Aoyagi K, Ohue C, Ida K, et al. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol 1999; 37:1802-1808. (Pubitemid 29235226)
6. Tobler LH, Stramer SL, Lee SR, et al. Performance of ORTHO HCV core antigen and Trak-C assays for detection of viraemia in pre-seroconversion plasma and whole blood donors. Vox Sang 2005; 89:201-207. (Pubitemid 41641099)
7. Mederacke I, Wedermeyer H, Ciesek S, et al. Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay. J Clin Virol 2009; 46:210-215.
8. Ross RS, Viazov S, Salloum S, et al. Analytical performance characteristics and clinical utility of a novel assay for total hepatitis c virus core antigen quantification. J Clin Microbiol 2010; 48:1161-1168.
9. Medici MC, Furlini G, Rodella A, et al. Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay. J Clin Virol 2011; 51:264-269.
10. Lee SR, Peterson J, Niven C, et al. Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of 'window-phase' blood donations. Vox Sang 2001; 80:19-23. (Pubitemid 35333902)
11. Muerhoff AS, Jiang L, Shah DO, et al. Detection of HCV core antigen in human serum and plasma with an automated analyzer. Transfusion 2002; 42:349-356.
12. Leary TP, Gutierrez RA, Muerhoff AS, Birkenmeyer LG, Desai SM, Dawson GJ. A chemiluminescent magnetic particle-based immunoassay for the detection of hepatitis C virus core antigen in human serum or plasma. J Med Virol 2006; 78:1436-1440. (Pubitemid 44533872)
13. Zhang H-Q, Li S-B, Want G-H, Chen K, Song X-G, Feng X-Y. Detection of hepatitis C virus core antigen for early diagnosis of hepatitis C virus infection in plasma donor in China. World J Gastroenterol 2007; 13:2738-2742. (Pubitemid 46964280)
14. Shah DO, Change LX, Cheng KY, et al. Combination HCV core antigen and antibody assay on a fully automated chemiluminescence analyzer. Transfusion 2003; 43:1067-1074. (Pubitemid 37022366)
15. Laperche S, Le Marrec N, Girault A, et al. Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection. J Clin Microbiol 2005; 43:3877-3883. (Pubitemid 41129675)
16. Zanetti AR, Romano L, Brunetto M, Colombo M, Bellati G, Tackney C. Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy. J Med Virol 2003; 70:27-30. (Pubitemid 36368861)
17. Miedouge M, Saune K, Kamar N, Rieu M, Rostaing L, Izopet J. Analytical evaluation of HCV core antigen and interest for HCV screening haemodialysis patients. J Clin Virol 2010; 48:18-21.
18. Tanaka E, Kiyosawa K, Matsumoto A, et al. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa. Hepatology 1996; 23:1330-1333. (Pubitemid 26181212)
19. Maynard M, Pradat P, Berthillon P, et al. Clinical relevance of total HCV core antigen testing for hepatitis monitoring and for predicting patients' response to therapy. J Viral Hepat 2003; 10:318-323. (Pubitemid 36801920)
20. González V, Padilla E, Diago M, et al. Clinical usefulness of total hepatitis C core antigen quantification to monitor the response to treatment with peginterferon alpha-2a plus ribavarin. J Viral Hepat 2005; 12:481-487. (Pubitemid 41224251)